Life Sciences
In addition to the Nectar Allergy Center in New York, the company's offerings include a compounding pharmacy, lab testing facility and telehealth network of allergists.
The raise brings the healthcare-focused firm's total committed capital to more than $1 billion.
Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.
Investigations sponsored by the ISS National Laboratory will be performed, including tissue chip investigations to study liver regeneration and the immune aging process.
The company will use the funds to expand its value-based cancer care network and extend its reach with health plans, employers and providers.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.
The life sciences company's Gut Intelligence Test will be available in 200 CVS locations and through the drugstore chain online.
The partnership will allow Molina's Virginia-based Medicare and healthcare marketplace members access to culturally competent maternal health experts.
Medicare Advantage insurtech company Clover Health and virtual care company Hims & Hers Health also reported earnings.
The partners are releasing a mobile app containing a digital version of the Lippincott Nursing Drug Handbook, complete with FDA updates.